TORONTO, ON / ACCESSWIRE / November 20, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND)(OTC PINK:BMNDF)(FRA:3XI) , a leading biotech company at the forefront of next-generation pharmaceuticals...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ) (FSE: 3XI), a leading biotech company in fast-acting psychedelics, announces today the Company’s completion of the development...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ), a leading biotech company in fast-acting psychedelics is pleased to announce that its Phase II clinical trial on N, N-dimethyltryptamine...
Today, NEO welcomes its newest corporate listing partner, Biomind Labs Inc. (“Biomind”), as it makes its public markets debut on the NEO Exchange. A biotechnology research and development company...